This White Paper from SP Scientific discusses the challenges associated with lyophilization of biologic drug products. Using a Quality by Design (QbD) approach with the Line of Sight™ (LOS) suite of equipment and technologies that provide a data-rich environment, many of these challenges are overcome. In particular, scaling-up of lyophilization from early development to full commercialization can be streamlined through use of scalable technologies available within the Line of Sight™ portfolio.
